MPH Health Care AG - Asset Resilience Ratio

Latest as of December 2025: 0.17%

MPH Health Care AG (93M1) has an Asset Resilience Ratio of 0.17% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 93M1 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€435.17K
≈ $508.76K USD Cash + Short-term Investments

Total Assets

€258.09 Million
≈ $301.73 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how MPH Health Care AG's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see MPH Health Care AG balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down MPH Health Care AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 93M1 liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €435.17K 0.17%
Total Liquid Assets €435.17K 0.17%

Asset Resilience Insights

  • Limited Liquidity: MPH Health Care AG maintains only 0.17% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

MPH Health Care AG Industry Peers by Asset Resilience Ratio

Compare MPH Health Care AG's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Senvest Capital Inc.
TO:SEC
Asset Management 1.75%
Nuveen Multi-Asset Income Fund
NYSE:NMAI
Asset Management 0.09%
Sprott Physical Silver
TO:PSLV
Asset Management 99.90%
Janus Henderson Group PLC
F:HDJA
Asset Management 18.51%
Compagnie du Cambodge
PA:CBDG
Asset Management 0.00%
Central Securities Corporation
NYSE MKT:CET
Asset Management 3.19%
A.F.P. Habitat
SN:HABITAT
Asset Management 7.59%
UTI Asset Management Company Limited
NSE:UTIAMC
Asset Management 8.10%

Annual Asset Resilience Ratio for MPH Health Care AG (2016–2025)

The table below shows the annual Asset Resilience Ratio data for MPH Health Care AG.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.17% €435.17K
≈ $508.76K
€258.09 Million
≈ $301.73 Million
+0.11pp
2024-12-31 0.06% €164.77K
≈ $192.64K
€291.06 Million
≈ $340.28 Million
-0.15pp
2023-12-31 0.20% €543.22K
≈ $635.08K
€266.35 Million
≈ $311.39 Million
-0.70pp
2022-12-31 0.91% €2.15 Million
≈ $2.51 Million
€236.99 Million
≈ $277.07 Million
-0.41pp
2021-12-31 1.31% €2.60 Million
≈ $3.04 Million
€198.00 Million
≈ $231.48 Million
-0.52pp
2020-12-31 1.83% €3.86 Million
≈ $4.52 Million
€210.71 Million
≈ $246.34 Million
+1.73pp
2019-12-31 0.10% €305.04K
≈ $356.62K
€293.14 Million
≈ $342.72 Million
+0.08pp
2018-12-31 0.02% €64.23K
≈ $75.10K
€286.25 Million
≈ $334.66 Million
-2.12pp
2017-12-31 2.14% €5.52 Million
≈ $6.45 Million
€257.38 Million
≈ $300.90 Million
-1.97pp
2016-12-31 4.11% €9.47 Million
≈ $11.07 Million
€230.33 Million
≈ $269.28 Million
--
pp = percentage points

About MPH Health Care AG

F:93M1 Germany Asset Management
Market Cap
$132.14 Million
€113.03 Million EUR
Market Cap Rank
#18861 Global
#1734 in Germany
Share Price
€26.40
Change (1 day)
-2.22%
52-Week Range
€17.25 - €29.70
All Time High
€47.41
About

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It operates through Beauty, Pharma, and Real Estate segments. The company offers medical-aesthetic beauty surgeries and treatments, as well as operation and provision of medical infrastructures for partner companies; and sells pharmaceuticals and medical products in the areas of oncology, HIV/AIDS, neurology… Read more